Autonomix Medical Income Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Selling, General & Admin	6.68	5.25	1.25	13.59
Research & Development	3.87	2.23	0.75	0
Operating Expenses	10.75	7.47	1.99	13.59
Operating Income	-10.75	-7.47	-1.99	-13.59
Interest Expense	-0.18	-0.08	-	-0.22
Interest & Investment Income	0.33	0.13	-	-
Other Non Operating Income (Expenses)	-3.03	-8	-	0.31
EBT Excluding Unusual Items	-13.63	-15.43	-1.99	-13.5
Other Unusual Items	-	-	-	0.17
Pretax Income	-13.63	-15.43	-1.99	-13.33
Net Income	-13.63	-15.43	-1.99	-13.33
Preferred Dividends & Other Adjustments	-	-	-	-0.49
Net Income to Common	-13.63	-15.43	-1.99	-12.84
Shares Outstanding (Basic)	1	1	1	0
Shares Outstanding (Diluted)	1	1	1	0
Shares Change (YoY)	17.62%	21.65%	480.20%	-
EPS (Basic)	-12.86	-21.09	-3.31	-123.94
EPS (Diluted)	-12.86	-21.09	-3.31	-123.94
Free Cash Flow	-8.05	-6.67	-1.85	-0.39
Free Cash Flow Per Share	-7.59	-9.12	-3.08	-3.74
EBITDA	-10.57	-7.39	-	-
D&A For EBITDA	0.18	0.08	-	-
EBIT	-10.75	-7.47	-1.99	-13.59

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q